Search research articles
Contact Us
Filters
Showing results (71-80 of 111) with videos related to
Page
of 12
Sort By:
Current Pain and Headache Reports
|
February 17, 2016
Botulinum Toxin: Pharmacology and Therapeutic Roles in Pain States
Shilpadevi Patil, Olga Willett, Terin Thompkins, et al.
Gene
|
April 2, 2013
Molecular cloning, expression, and hormonal regulation of the chicken microsomal triglyceride transfer protein
N Erwin Ivessa, Edward Rehberg, Bernadette Kienzle, et al.
Diabetes Technology & Therapeutics
|
October 13, 2007
A high-throughput population screening system for the estimation of genetic risk for type 1 diabetes: an application for the TEDDY (the Environmental Determinants of Diabetes in the Young) study
Minna Kiviniemi, Robert Hermann, Jussi Nurmi, et al.
Diabetologia
|
July 19, 2005
The effect of HLA class II, insulin and CTLA4 gene regions on the development of humoral beta cell autoimmunity
Robert Hermann, A P Laine, R Veijola, et al.
British Journal of Clinical Pharmacology
|
October 22, 2009
Effects of rifampicin on the pharmacokinetics of roflumilast and roflumilast N-oxide in healthy subjects
Nassr Nassr, Andreas Huennemeyer, Rolf Herzog, et al.
Journal of Clinical Pharmacology
|
February 12, 2014
A FIM study to assess safety and exposure of inhaled single doses of AP301-A specific ENaC channel activator for the treatment of acute lung injury
Richard Schwameis, Sandra Eder, Helmut Pietschmann, et al.
Journal of Autoimmunity
|
June 8, 2006
Enteral virus infections in early childhood and an enhanced type 1 diabetes-associated antibody response to dietary insulin
Miia Mäkelä, Outi Vaarala, Robert Hermann, et al.
Diabetes
|
August 27, 2010
Effect of HLA class I and class II alleles on progression from autoantibody positivity to overt type 1 diabetes in children with risk-associated class II genotypes
Kati Lipponen, Zsofia Gombos, Minna Kiviniemi, et al.
Journal of Neuroinflammation
|
October 19, 2013
Glatiramer acetate treatment effects on gene expression in monocytes of multiple sclerosis patients
Madhan Thamilarasan, Michael Hecker, Robert Hermann Goertsches, et al.
Clinical Pharmacology and Therapeutics
|
January 25, 2003
Effects of age and sex on the disposition of retigabine
Robert Hermann, Geraldine M Ferron, Katharina Erb, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 111) with videos related to
Sort By:
Page
of 12
Current Pain and Headache Reports
|
February 17, 2016
Botulinum Toxin: Pharmacology and Therapeutic Roles in Pain States
Shilpadevi Patil, Olga Willett, Terin Thompkins, et al.
Gene
|
April 2, 2013
Molecular cloning, expression, and hormonal regulation of the chicken microsomal triglyceride transfer protein
N Erwin Ivessa, Edward Rehberg, Bernadette Kienzle, et al.
Diabetes Technology & Therapeutics
|
October 13, 2007
A high-throughput population screening system for the estimation of genetic risk for type 1 diabetes: an application for the TEDDY (the Environmental Determinants of Diabetes in the Young) study
Minna Kiviniemi, Robert Hermann, Jussi Nurmi, et al.
Diabetologia
|
July 19, 2005
The effect of HLA class II, insulin and CTLA4 gene regions on the development of humoral beta cell autoimmunity
Robert Hermann, A P Laine, R Veijola, et al.
British Journal of Clinical Pharmacology
|
October 22, 2009
Effects of rifampicin on the pharmacokinetics of roflumilast and roflumilast N-oxide in healthy subjects
Nassr Nassr, Andreas Huennemeyer, Rolf Herzog, et al.
Journal of Clinical Pharmacology
|
February 12, 2014
A FIM study to assess safety and exposure of inhaled single doses of AP301-A specific ENaC channel activator for the treatment of acute lung injury
Richard Schwameis, Sandra Eder, Helmut Pietschmann, et al.
Journal of Autoimmunity
|
June 8, 2006
Enteral virus infections in early childhood and an enhanced type 1 diabetes-associated antibody response to dietary insulin
Miia Mäkelä, Outi Vaarala, Robert Hermann, et al.
Diabetes
|
August 27, 2010
Effect of HLA class I and class II alleles on progression from autoantibody positivity to overt type 1 diabetes in children with risk-associated class II genotypes
Kati Lipponen, Zsofia Gombos, Minna Kiviniemi, et al.
Journal of Neuroinflammation
|
October 19, 2013
Glatiramer acetate treatment effects on gene expression in monocytes of multiple sclerosis patients
Madhan Thamilarasan, Michael Hecker, Robert Hermann Goertsches, et al.
Clinical Pharmacology and Therapeutics
|
January 25, 2003
Effects of age and sex on the disposition of retigabine
Robert Hermann, Geraldine M Ferron, Katharina Erb, et al.
Page
of 12